ASPIRE PHARMA LIMITED
Significant control: Aphl 2 Limited (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Aspire Pharma Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Aspire Pharma Limited sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ASPIRE PHARMA LIMITED is an active private limited company (company number 06828501) incorporated on 24 February 2009, registered in Godalming. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest full accounts cover the period ending 31 December 2025, showing net assets of £87.62m and cash of £7.03m, with 114 employees on average. Net assets rose 33% on the prior period (£65.80m).
By net assets it sits in the top quarter of 50 comparable companies in Surrey (median £3,179, upper quartile £541k).
Ownership and control
- Aphl 2 Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Aspire Pharma Holdings Limited
- owns 75–100% of shares
- Aphl 1 Limited
- owns 75–100% of shares
- holds 75–100% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 24 February 200917 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 10 March 2027in 136 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Full
- Size band
- MediumCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £87.62m | £7.03m | — | £34.45m | — | £21.82m | 114 |
| 31 December 2024 | £65.80m | £8.51m | — | £29.46m | — | £23.09m | 100 |
| 31 December 2023 | — | — | — | — | — | — | — |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £87,624,000 at 31 December 2025
- Net assets up 10% or more on the prior period+33.2% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.32
- Cash at bank of £50,000 or moreCash £7,034,000
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 24 February 2009
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 340 days
- Confirmation statement duein 136 days
- Accounts period endNet assets £87.62m · full accounts
- Accounts period endNet assets £65.80m · full accounts
- Accounts period end
- Incorporated
Similar companies in Surrey
- LANTHEUS MI UK LIMITEDGodalming, · inc. Apr 2008
- TORRENT PHARMA (UK) LTDCrawley · inc. May 2010
- WARNEFORD HEALTHCARE LIMITEDLiphook · inc. Sept 2010
- KORLYNS THERAPEUTICS LIMITEDRedhill · inc. Apr 2007
- MCALL CONSULTING LTDHorley · inc. May 2011
- APPIA HEALTHCARE LIMITEDGuildford · inc. Sept 2011
All companies incorporated on 24 February 2009 · in Feb 2009.
Reminders for ASPIRE PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.